Increased mRNA levels of xeroderma pigmentosum complementation group B (XPB) and Cockayne’s syndrome complementation group B (CSB) without increased mRNA levels of multidrug-resistance gene (MDR1) or metallothionein-II (MT-II) in platinum-resistant human ovarian cancer tissues

✍ Scribed by Meenakshi Dabholkar; Keith Thornton; Justine Vionnet; Frieda Bostick-Bruton; Jing Jie Yu; Eddie Reed

• Book ID: 113992427
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 493 KB
• Volume: 60
• Category: Article
• ISSN: 0006-2952
• DOI: 10.1016/s0006-2952(00)00448-2